3b Blackbio Dx Ltd vs Asarfi Hospital Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Asarfi Hospital Ltd changed from 31 on March 2024 to 20 on March 2026 . This represents a CAGR of -13.59% over 3 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Asarfi Hospital Ltd changed from ₹ 128.55 crore on March 2024 to ₹ 333.63 crore on March 2026 . This represents a CAGR of 37.42% over 3 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Asarfi Hospital Ltd for the Jun '26 is ₹ 48.1 crore as compare to the Mar '26 revenue of ₹ 45.89 crore. This represent the growth of 4.82% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Asarfi Hospital Ltd for the Jun '26 is ₹ 10.02 crore as compare to the Mar '26 ebitda of ₹ 8.36 crore. This represent the growth of 19.86% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Asarfi Hospital Ltd changed from ₹ 1.45 crore to ₹ 4.27 crore over 9 quarters. This represents a CAGR of 61.61% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Asarfi Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Asarfi Hospital Ltd

Asarfi Hospital Limited was originally incorporated as Private Limited Company in the name of 'Asarfi Hospital Private Limited' on October 4, 2005 issued by Registrar of Companies, Bihar & Jharkhand.
Subsequently, status of the Company was converted into Public Limited and name of the Company was changed to 'Asarfi Hospital Limited' vide a fresh Certificate of Incorporation dated February 08, 2012 issued by Registrar of Companies, Jharkhand. Asarfi Ltd is a 250 bedded Multi Speciality Hospital, which is serving people for more than one and half decade by providing healthcare services in Dhanbad, Jharkhand.
Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited).
The Company is an integrated healthcare service provider, committed to deliver quality healthcare services to their patients in modern facilities that includes prevention, best treatment and proper rehabilitation.

FAQs for the comparison of 3B Blackbio DX Ltd and Asarfi Hospital Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Asarfi Hospital Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Asarfi Hospital Ltd is 334 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Asarfi Hospital Ltd?

The stock performance of 3B Blackbio DX Ltd and Asarfi Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Asarfi Hospital Ltd?

As of October 25, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Asarfi Hospital Ltd stock price is INR ₹170.1.

How do dividend payouts of 3B Blackbio DX Ltd and Asarfi Hospital Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Asarfi Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.